Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...
ORLANDO, FL / ACCESS Newswire / March 19, 2026 / Unusual Machines, Inc. (NYSE American:UMAC) ("Unusual Machines" or the ...